These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 34755033)

  • 61. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 62. Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
    Amiot A; Bourrier A; Gornet JM; Dewit O; Nancey S; Altwegg R; Abitbol V; Laharie D; Reenaers C; Gagnière C; Buisson A; Nachury M; Viennot S; Vuitton L; Stefanescu C; Marteau P; Bouguen G; Seksik P;
    Infect Prev Pract; 2023 Mar; 5(1):100267. PubMed ID: 36601289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis.
    Blanchard JF; Bernstein CN; Wajda A; Rawsthorne P
    Am J Epidemiol; 2001 Aug; 154(4):328-35. PubMed ID: 11495856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul.
    Kim ES; Chen M; Lee J; Lee CK; Kim YS
    Intest Res; 2016 Jul; 14(3):224-30. PubMed ID: 27433144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A SPECIAL MEETING REVIEW EDITION: Highlights in Inflammatory Bowel Disease From the 14th Congress of ECCO: A Review of Selected Presentations From the 14th Congress of the European Crohn's and Colitis Organisation (ECCO) • March 6-9, 2019 • Copenhagen, Denmark
    Gastroenterol Hepatol (N Y); 2019 May; 15(5 Suppl 2):1-24. PubMed ID: 31632213
    [No Abstract]   [Full Text] [Related]  

  • 70. Commonalities in the time trends of Crohn's disease and ulcerative colitis.
    Delcò F; Sonnenberg A
    Am J Gastroenterol; 1999 Aug; 94(8):2171-6. PubMed ID: 10445545
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
    Ling KL; Hilmi I; Raja Ali RA; Leong RWL; Leung WK; Ng SC; Wu KC; Chen MH; Ran ZH; Hisamatsu T; Ahuja V; Makharia GK; Banerjee R; Wei SC; Wu DC; Pisespongsa P; Ye BD; Sollano J; Simadibrata M; Chuah SW; Ooi CJ
    JGH Open; 2020 Jun; 4(3):320-323. PubMed ID: 32514431
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Familial occurrence and inheritance studies in inflammatory bowel disease.
    Binder V; Orholm M
    Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.
    Rose KL; Sherman PM; Cooke-Lauder J; Mawani M; Benchimol EI; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S81-S91. PubMed ID: 31294388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
    Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
    United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Crohn's disease and ulcerative colitis: morbidity and mortality.
    Rod Riley
    Health Rep; 1990; 2(4):343-59. PubMed ID: 2101290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
    Lashner BA; Shaheen NJ; Hanauer SB; Kirschner BS
    Am J Gastroenterol; 1993 Mar; 88(3):356-9. PubMed ID: 8438840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD.
    Roy S; Sheikh SZ; Furey TS
    Sci Rep; 2021 Aug; 11(1):16522. PubMed ID: 34389789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.